TRULANCE Trademark

Trademark Overview

On Wednesday, May 18, 2016, a trademark application was filed for TRULANCE with the United States Patent and Trademark Office. The USPTO has given the TRULANCE trademark a serial number of 87042213. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, August 12, 2023. This trademark is owned by Synergy Pharmaceuticals Inc.. The TRULANCE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of gastrointestinal swelling, bloating, pain, inflammation, and diarrhea; pharmaceutical preparations for use in the treatment of constipation, irritable bowel syndrome, colitis, gastrointestinal disorders and gastrointestinal diseases; gastrointestinal hormone analogue preparations for medical purposes; laxatives; antiemetics; anti-diarrheal and anti-inflammatory pharmaceutical preparations all of the aforesaid excluding pharmaceutical preparations for the treatment of diabetes
trulance

General Information

Serial Number87042213
Word MarkTRULANCE
Filing DateWednesday, May 18, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, August 12, 2023
Registration Number5242709
Registration DateTuesday, July 11, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2016

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of gastrointestinal swelling, bloating, pain, inflammation, and diarrhea; pharmaceutical preparations for use in the treatment of constipation, irritable bowel syndrome, colitis, gastrointestinal disorders and gastrointestinal diseases; gastrointestinal hormone analogue preparations for medical purposes; laxatives; antiemetics; anti-diarrheal and anti-inflammatory pharmaceutical preparations all of the aforesaid excluding pharmaceutical preparations for the treatment of diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 24, 2016
Primary Code005
First Use Anywhere DateTuesday, February 28, 2017
First Use In Commerce DateTuesday, February 28, 2017

Trademark Owner History

Party NameBAUSCH HEALTH IRELAND LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressDUBLIN 24
IE
Party NameSynergy Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10170
Party NameSynergy Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10170
Party NameSynergy Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10170

Trademark Events

Event DateEvent Description
Sunday, August 13, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, August 12, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, August 12, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, February 14, 2023TEAS SECTION 8 & 15 RECEIVED
Wednesday, February 8, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 18, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, December 28, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, December 14, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, August 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 11, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sunday, May 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, May 3, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, May 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, May 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, May 3, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 29, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 11, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, June 7, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 6, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 5, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, May 5, 2017USE AMENDMENT FILED
Wednesday, May 31, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 5, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, December 27, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 12, 2016CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, November 29, 2016ASSIGNED TO PETITION STAFF
Thursday, November 17, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, November 1, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2016PUBLISHED FOR OPPOSITION
Wednesday, October 12, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 26, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 21, 2016ASSIGNED TO LIE
Thursday, September 8, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 8, 2016EXAMINER'S AMENDMENT ENTERED
Thursday, September 8, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 8, 2016EXAMINERS AMENDMENT E-MAILED
Thursday, September 8, 2016EXAMINERS AMENDMENT -WRITTEN
Friday, September 2, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 2, 2016NON-FINAL ACTION E-MAILED
Friday, September 2, 2016NON-FINAL ACTION WRITTEN
Thursday, September 1, 2016ASSIGNED TO EXAMINER
Tuesday, May 24, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 21, 2016NEW APPLICATION ENTERED

Related Keywords

trulance preparations pharmaceutical gastrointestinal treatment anti purposes laxatives analogue antiemetics medical